Globus Medical (BSP:G2ME34) SpecialCharges

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:G2ME34 Globus Medical Inc BSP:G2ME34
26 GF Score
Price R$52.00
GF Value R$58.52
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Globus Medical SpecialCharges?

Special Charges only applies to banks.

BSP:G2ME34
26GF Score
Globus Medical Inc BSP:G2ME34
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Globus Medical (BSP:G2ME34) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of R$52.00 is trading 11.1% below its estimated GF Value™ of R$58.52. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for BSP:G2ME34:

  • SpecialCharges:
  • GF Value™: R$58.52 vs. price of R$52.00 (11.1% below fair value)
  • GF Score™: 26/100 with 5 warning signs

No single metric tells the full story. See the BSP:G2ME34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Globus Medical Business Description

Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
26GF Score

Get the complete analysis for BSP:G2ME34

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$52.00
Price
R$58.52
GF Value